Hillard Lazarus, MD, Rajneesh Nath, MD, Alexander Perl, MD and Swaminathan Iyer, MD

Experts discuss the phase III SIERRA trial, which recently demonstrated durable complete responses in patients with acute myeloid leukemia<br /> &nbsp;